Related Experiment Video
Updated: Jan 14, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Examining Colorectal Cancer Treatment Patterns and Outcomes in Asian American, Native Hawaiian, and Pacific Islander
Guanming Chen1, Zhigang Xie2,3,4, Ilyas Sahin5
1Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, School of Pharmacy, San Francisco, CA, USA.
Purpose:
Asian Americans, Native Hawaiians, and Pacific Islanders (AANHPI) are the fastest-growing racial and ethnic group in the U.S., yet they face significant, poorly characterized disparities in colorectal cancer (CRC) care. Disaggregated data is crucial for understanding and addressing these disparities within the community.
Methods:
Using the 2020 National Cancer Database (NCDB), we conducted a retrospective cohort study to examine treatment patterns and overall survival (OS) among AANHPI and non-Hispanic White (NHW) patients diagnosed with Stage I to IV CRC. We employed multivariable-adjusted logistic regression and Cox proportional hazard models to assess the risk of delayed cancer treatment and mortality across five geographic AANHPI subpopulations.
Results:
Among 873,622 patients with CRC, 42,026 were AANHPI patients (mean age, 63.2 years [SD: 14.1], 48% female), of whom 31.3% were East Asian. Compared to NHW patients, patients identified as East Asian, Southeast Asian, and Other Asian were significantly more likely to experience delayed cancer-related treatment (adjusted Odds Ratio [95% confidence interval],1.26 [1.19-1.33], 1.31 [1.22-1.40], and 1.29 [1.21-1.39], respectively). Meanwhile, AANHPI subpopulations demonstrated significantly better OS across cancer stages I-IV (adjusted Hazard Ratio range: 0.55 [Other Asian with stage I] - 0.90 [Southeast Asian with stage IV]). Patients who received surgery, chemotherapy or immunotherapy as their first-line treatment had significant risk reduction compared to those who did not undergo systemic treatment, particularly among individuals diagnosed with stage III or IV CRC.
Conclusion:
Despite experiencing significant delays in cancer-related care, AANHPI patients demonstrated superior OS compared to NHW patients across all CRC stages. This paradoxical finding of treatment delays coupled with improved survival outcomes warrants further investigation into potential protective factors and underscores the importance of disaggregated approaches to understanding disparities within the diverse AANHPI populations.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...